Kytopen collaborates with BlueWhale Bio for cell therapy manufacturing
Both will develop a non-viral manufacturing workflow designed to eliminate key bottlenecks and accelerate the delivery of lifesaving engineered cell therapies to patients
Both will develop a non-viral manufacturing workflow designed to eliminate key bottlenecks and accelerate the delivery of lifesaving engineered cell therapies to patients
Accelerating RNA-based therapeutic solutions for customers through co-development of products and formulation support
CGX-926 is the first clinical candidate addressing MC4R-deficient genetic obesity
The trial is the largest to date evaluating Leqvio and the first to focus on patient-centered outcomes
ITP is a disease of complex immune dysregulation leading to low platelet counts, bleeding, and reduced quality of life
First Indian company to follow global recommendations in accordance with the World Health Organisation (WHO)
Enters the high growth vitamins, minerals and supplements segment for adults, paediatrics, and animal health
Subscribe To Our Newsletter & Stay Updated